First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

Por Clumeck, Nathan, Mwamba, Claude, Kabeya, Kabamba, Matanda, Serge, Vaira, Dolorès, Necsoi, Coca, Kadiebwe, David, Delforge, Marc, Kasamba, Eric, Milolo, Chantal, Ilunga, Joe, Kapend, Liévin
Publicado em 2014

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial

Por Clumeck, Nathan, Mwamba, Claude, Kabeya, Kabamba, Calvez, Vincent, Matanda, Serge, Vaira, Dolorès, Peytavin, Gilles, Necsoi, Coca, Delforge, Marc, Kadiebwe, David, Milolo, Chantal, Ilunga, Joe, Kapend, Liévin
Publicado no BMC Infect Dis (2014)